Summary
Tim Kunz is a Senior Scientist at Thermo Fisher Scientific embedded with Vertex’s Type 1 Diabetes team, applying 11 years of expertise in stem cell biology, beta cell differentiation, and translational diabetes to advance stem cell–derived islet cell-replacement therapies. With a PhD in developmental and regenerative biology from Harvard and training in the Melton and Mahony labs, he uniquely bridges wet-lab experimentation and computational approaches to design data-informed strategies that boost performance, reproducibility, and throughput. His work spans molecular biology, tissue culture, mouse genetics, and in silico perturbation screening to accelerate maturation and function of beta-like cells. Motivated by solving complex biological and manufacturing challenges, he combines hands-on assay development with machine-learning–driven analysis—an uncommon mix that helps translate regenerative medicine toward real-world delivery.
11 years of coding experience
5 years of employment as a software developer
Bachelor of Science - BS, Biochemistry and Molecular Biology, Bachelor of Science - BS, Biochemistry and Molecular Biology at Penn State University
Doctor of Philosophy - PhD, Biology and Biomedical Sciences, Doctor of Philosophy - PhD, Biology and Biomedical Sciences at Harvard University